Standard BioTools 株価情報 (NASDAQ: LAB)

最新ニュース Standard BioTools (NASDAQ:LAB) 株価情報

Standard BioTools

Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.

Long Ideas

News

Penny Stocks

Insider Trades

Markets

Trading Ideas

CYAN

バタフライ・ネットワークおよびその他2つの5ドル未満の株ダウ平均株価指数は金曜日に50ドル以上上昇して取引を終えた。内部者が株を売買した場合、それは同社の見通しに対する彼らの信頼または懸念を示唆する。ペニー株に興味を持つ投資家やトレーダーは、この要素を総合的な投資や取引の意思決定の一因と考えることができよう。

ダウ平均株価指数は50ドルの上昇を記録　上昇の要因は？

Standard BioTools Inc

Direxion Daily S&P Biotech Bear 3X Shares

LABORATORIOS FARMACEUTICO by LABORATORIOS FARMACEUTICOS ROVI SA

Laboratorios Farmaceuticos Rovi SA

Landos Biopharma Inc COM NEW

LABS Group

Direxion Daily S&P Biotech Bull 3X Shares

METASPHERE LABS INC by METASPHERE LABS INC.

Metasphere Labs Inc

Piper Sandler analyst Mark Lear maintains Magnolia Oil &amp; Gas (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MGY#NYSE">MGY</a>) with a Neutral and lowers the price target from $25 to $24.

Price Target

Analyst Ratings

Piper Sandler Maintains Neutral on Magnolia Oil & Gas, Lowers Price Target to $24

VCI Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VCIG#NASDAQ">VCIG</a>) reported quarterly earnings of $54.74 per share. This is a 72.67 percent decrease over earnings of $200.28 per share from the same period last year. The company reported $27.82 million in sales this quarter. This is a 40.64 percent increase over sales of $19.79 million the same period last year.

Earnings

VCIG

VCI Global FY EPS $54.74 Down From $200.28 YoY, Sales $27.82M Up From $19.79M YoY

Piper Sandler analyst Mark Lear maintains Diamondback Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FANG#NASDAQ">FANG</a>) with a Overweight and lowers the price target from $234 to $225.

FANG

Piper Sandler Maintains Overweight on Diamondback Energy, Lowers Price Target to $225

NuScale Power Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SMR#NYSE">SMR</a>) shares surged 21.4% to $21.60 on Tuesday following the <a href="https://www.benzinga.com/pressreleases/25/05/b45359929/nuscale-power-reports-first-quarter-2025-results">release</a> of its first-quarter earnings after Monday&#8217;s close.
What To Know: The company <a href="https://www.benzinga.com/news/earnings/25/05/45361335/nuscale-power-reports-q1-results-details">reported</a> quarterly revenue of $13.4 million, significantly surpassing analysts&#8217; expectations of $4.26 million. The revenue boost was attributed to progress on its FEED Phase 2 project and a Technology License Agreement for Romania's RoPower Doicești power plant.
NuScale reduced its quarterly operating expenses by $2.3 million year-over-year to $42.3 million, largely due to lower R&amp;D costs as the company advances from development toward commercialization. The company&#8217;s net loss from operations narrowed to $35.3 million from $44.0 million in the same quarter last year.
Read Also: <a href="https://www.benzinga.com/news/25/05/45380609/applovin-stock-surges-on-strong-q1-earnings-and-tariff-truce-tailwinds">AppLovin Stock Surges On Strong Q1 Earnings And Tariff Truce Tailwinds</a>
CEO John Hopkins <a href="https://www.benzinga.com/news/earnings/25/05/45361335/nuscale-power-reports-q1-results-details">emphasized</a> NuScale's ongoing momentum as the only SMR provider with US NRC design approval. He noted that 12 reactor modules are already in production, with a target delivery date set for 2030.
NuScale, along with partner ENTRA1 Energy, is in advanced discussions with a range of potential customers, including governments, data centers and energy firms. 
The company ended the quarter with $521.4 million in liquidity and raised $102.4 million through its ATM equity program, reinforcing its capital position as it scales operations.
Read Also: <a href="https://www.benzinga.com/25/05/45378427/trump-wants-to-kickstart-nuclear-development-these-5-stocks-could-boom">Trump Wants To Kickstart Nuclear Development: These 5 Stocks Could Boom</a>
<h2 class="wp-block-heading">How To Buy SMR Stock</h2>
Besides going to a brokerage platform to purchase a share &#8211; or fractional share &#8211; of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument. 
For example, in NuScale Power&#8217;s case, it is in the Industrials sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, SMR has a 52-week high of $32.30 and a 52-week low of $5.86.

NuScale (SMR) Stock Surges 21% After Smashing Q1 Revenue Estimates

TD Cowen analyst Joseph Thome initiates coverage on Bright Minds Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DRUG#NASDAQ">DRUG</a>) with a Buy rating.

Initiation

DRUG

TD Cowen Initiates Coverage On Bright Minds Biosciences with Buy Rating

Piper Sandler analyst Mark Lear maintains EQT (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQT#NYSE">EQT</a>) with a Neutral and raises the price target from $35 to $48.

Piper Sandler Maintains Neutral on EQT, Raises Price Target to $48

WIIM

Western Digital shares are trading higher after the company announced a $2 billion buyback program.

Piper Sandler analyst Mark Lear maintains Devon Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVN#NYSE">DVN</a>) with a Overweight and lowers the price target from $56 to $53.

Piper Sandler Maintains Overweight on Devon Energy, Lowers Price Target to $53

HOOD

Robinhood shares are trading higher after the company announced a deal to acquire WonderFi.

ARRY

FSLR

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

Shares of solar stocks are trading higher on reports indicating the House GOP budget will cut but not remove wind and solar tax credits.

UBS analyst Chris Kuntarich maintains Life360 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIF#NASDAQ">LIF</a>) with a Buy and raises the price target from $55 to $57.

UBS Maintains Buy on Life360, Raises Price Target to $57

Piper Sandler analyst Mark Lear maintains Coterra Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CTRA#NYSE">CTRA</a>) with a Overweight and lowers the price target from $37 to $36.

CTRA

Piper Sandler Maintains Overweight on Coterra Energy, Lowers Price Target to $36

Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) shares are trading higher on Tuesday after the <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/25/05/45359644/under-armour-q4-earnings-preview-are-investors-better-off-hiding-out-literally-under-armor-than-buying-stock" rel="noreferrer noopener">company reported fourth-quarter results.</a>
The company reported:
<ul class="wp-block-list">
<li>Adjusted earnings per share of 8 cents loss, in line with the<a href="https://www.benzinga.com/pressreleases/25/05/n45371092/under-armour-reports-fourth-quarter-fiscal-2025-results-provides-first-quarter-fiscal-2026-outlook" target="_blank" rel="noreferrer noopener"> analyst consensus estimate.</a></li>
<li>Quarterly sales of $1.18 billion (down 11% year over year) outpaced the Street view of $1.16 billion.</li>
<li>North American revenue decreased 11% to&nbsp;$689 million, while international revenue declined 13% to&nbsp;$489 million.</li>
<li>Gross margin&nbsp;increased 170 basis points to 46.7 percent, primarily driven by supply chain benefits, including lower product and freight costs.</li>
<li>Inventory&nbsp;was down 1% to&nbsp;$946 million.</li>
<li>Cash and equivalents of $501 million.</li>
</ul>
The firm confirmed that there were no outstanding borrowings under the company&#8217;s $1.1 billion revolving credit facility.
Also Read:<a target="_blank" href="https://www.benzinga.com/news/earnings/25/05/45368490/under-armour-cyberark-software-and-3-stocks-to-watch-heading-into-tuesday" rel="noreferrer noopener"> Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday</a>
In May 2024, Under Armour launched a restructuring plan aimed at boosting financial and operational efficiency.
The total expected cost ranges from $140 million to $160 million, including up to $90 million in cash expenses and $70 million in non-cash charges.
By the end of fourth-quarter, the company had already spent $89 million under the plan—$55 million in cash and $34 million in non-cash charges.
Outlook: &#8220;As we look toward fiscal 2026 amid a complex macroeconomic backdrop, our sharpened execution, alignment, and focus – bolstered by the move to a category-led operating model – equip us to navigate ongoing volatility with resilience,&#8221; said Under Armour President and CEO Kevin Plank.
Under Armour expects first-quarter adjusted EPS to range between one cent and three cents. The company forecasts revenue between $1.125 billion and $1.137 billion, slightly below the $1.167 billion estimate.
Price Action: UAA shares are trading higher by 0.64% to $6.260&nbsp;at last check Tuesday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45374327/bitcoin-ethereum-xrp-dogecoin-wobble-but-traders-see-a-shopping-opportunity" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, XRP, Dogecoin Wobble, But Traders See A &#8216;Shopping&#8217; Opportunity</a></li>
</ul>
Image: Shutterstock

Equities

Guidance

General

Under Armour Tops Q4 Sales Estimates But Quarterly Sales Dip 11%

"The country is edging dangerously close to a constitutional crisis," Sen. Amy Klobuchar (D-MN) warned during an April 21 appearance on <a href="https://edition.cnn.com/2025/04/20/politics/video/sotu-senator-klobuchar-warns-america-is-close-to-constitutional-crisis">CNN's "State of the Union</a>".
She accused President Donald Trump of trying to "pull us down into the sewer of a crisis," referencing the administration's refusal to comply with a Supreme Court order concerning the wrongful deportation of Kilmar Ábrego Garcia, a Maryland resident mistakenly deported to El Salvador.&nbsp;&nbsp;
The situation has stirred bipartisan pushback, legal scrutiny, and concerns over executive power, especially in how federal agencies respond to judicial orders.
Don't Miss:
<ul class="wp-block-list">
<li>Deloitte's fastest-growing software company partners with Amazon, Walmart &amp; Target – <a href="https://www.benzinga.com/money/mode-mobile-2">Many are rushing to grab 4,000 of its pre-IPO shares for just $0.30/share!</a></li>
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing —<a href="https://www.benzinga.com/money/boxabl"> this is your last chance to become an investor for $0.80 per share.</a></li>
</ul>
<h2 class="wp-block-heading">Courts, Congress, And A Constitutional Tug-of-War</h2>
Klobuchar called on the courts to consider holding involved officials in contempt and suggested the appointment of a special prosecutor, to determine who authorized or failed to reverse García's deportation. The administration argued that diplomatic constraints limit their ability to retrieve him.
Hours before Klobuchar's comments, the <a href="https://d3i6fh83elv35t.cloudfront.net/static/2025/04/041925zr_c18e.pdf">Supreme Court</a> temporarily halted the deportation of Venezuelan migrants detained at the Bluebonnet Detention Center in North Texas.&nbsp;
The Trump administration had moved to deport the group under the Alien Enemies Act of 1798, citing suspected ties to the Tren de Aragua gang. The American Civil Liberties Union filed an emergency appeal, arguing that migrants were being removed without due process.
The Supreme Court agreed to block the deportations until further order, citing concerns over the lack of legal review for those targeted under the centuries-old law.
Trending: The average American couple has saved this much money for retirement —<a href="http://www.benzinga.com/money/smartasset"> How do you compare</a>?
Justices Samuel Alito and Clarence Thomas rejected the majority's ruling. In his dissent, Alito criticized the seven-justice majority for acting "literally in the middle of the night." He claimed the order was issued without input from lower courts or responses from the federal government.
Alito argued that the emergency ruling had "dubious factual support," and lacked a clear legal foundation. In his view, the applicants did not demonstrate they were in "imminent danger of removal."&nbsp;
The Supreme Court on April ruled that officials must facilitate García's return, which has yet to be honored. García remains in El Salvador, where he was previously detained at CECOT, one of the region's largest detention centers.
See Also: <a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a>
Sen. Chris Van Hollen (D-MD) visited El Salvador on April 17 to meet with García. Although he was initially denied access, Van Hollen was eventually able to meet with García at a hotel in San Salvador before returning to the U.S.
Subsequently, on April 21, a delegation of four House Democrats—Reps. Robert Garcia (D-CA), Maxwell Frost (D-FL), Yassamin Ansari (D-AZ), and Maxine Dexter (D-OR)—visited San Salvador to advocate for García's return.
Meanwhile, the<a href="https://statesunited.org/resources/facts-about-alien-enemies-act/"> States United Democracy Center</a> warned that the Trump administration's use of the Alien Enemies Act without congressional oversight raises new constitutional questions about separation of powers in peacetime deportations.
Read Next:
<ul class="wp-block-list">
<li>Nancy Pelosi Invested $5 Million In An AI Company Last Year — <a href="https://www.benzinga.com/money/elf-labs-ym?v=123">Here's How You Can Invest In Multiple Pre-IPO AI Startups With Just $1,000.</a></li>
<li>‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-2">You can invest today for just $0.30/share with a $1000 minimum.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Sen. Amy Klobuchar Sounds Alarm On Democracy – 'Trump Is Trying To Pull Us Down Into The Sewer Of A Crisis'

Insulet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PODD#NASDAQ">PODD</a>) has outperformed the market over the past 15 years by 10.99% on an annualized basis producing an average annual return of 22.69%. Currently, Insulet has a market capitalization of $22.63 billion. 
Buying $1000 In PODD: If an investor had bought $1000 of PODD stock 15 years ago, it would be worth $21,273.51 today based on a price of $321.56 for PODD at the time of writing.
<h3>Insulet's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747151121_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PODD

$1000 Invested In Insulet 15 Years Ago Would Be Worth This Much Today

UBS analyst Michael Goldsmith maintains Peakstone Realty Tr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKST#NYSE">PKST</a>) with a Buy and raises the price target from $14 to $15.

PKST

UBS Maintains Buy on Peakstone Realty Tr, Raises Price Target to $15

Goldman Sachs analyst Neil Mehta upgrades Valero Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLO#NYSE">VLO</a>) from Neutral to Buy and raises the price target from $127 to $154.

Upgrades

Goldman Sachs Upgrades Valero Energy to Buy, Raises Price Target to $154

<a href="https://www.youtube.com/watch?v=wj1QOz3iuCE">https://www.youtube.com/watch?v=wj1QOz3iuCE</a>

President Trump Says In Good Shape To Pass Tax Bill; Says Tax Bill Will Be Like Rocket Ship

UBS analyst Jay Sole maintains Ralph Lauren (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RL#NYSE">RL</a>) with a Buy and raises the price target from $300 to $335.

UBS Maintains Buy on Ralph Lauren, Raises Price Target to $335

What you need to know:
<ul>
<li>Verizon announces a substantial $5 billion commitment over the next five years with the launch of a new Small Business Supplier Accelerator.</li>
<li>Verizon Small Business Digital Ready launched a new grant cycle where eligible small businesses can apply for $10,000 grants (open until June 30, 2025).</li>
</ul>
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Verizon today announced a commitment to invest $5 billion over the next five years in US small business suppliers with the launch of its new Small Business Supplier Accelerator. The program helps create a pipeline for American small businesses, many of which are owned by veterans, to work with Verizon and other large corporations. This program is designed to strengthen small businesses — the backbone of the US economy — and to help the country create a more resilient supply chain.

Verizon Announces $5B Commitment to Boost US Small Business Suppliers Through New Accelerator Program

Management

Press Releases

Standard BioTools Appoints Alex Kim as Chief Financial Officer

Health Care

Standard BioTools to Present at the 43rd Annual J.P. Morgan Healthcare Conference

Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

Standard BioTools Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call on February 26, 2025

Standard BioTools Reports Fourth Quarter and Full Year 2024 Financial Results

Standard BioTools to Participate in Upcoming Investor Conferences

Standard BioTools Schedules First Quarter Earnings Conference Call on May 6, 2025

Standard BioTools Announces New Product Innovations in Plasma and Single-Cell Proteomics at AACR 2025

Standard BioTools Reports First Quarter 2025 Financial Results

AbCellera Biologics

Adaptive Biotechnologies Corporation - Common Stock

Adaptive Biotechnologies

Atlantic International Corp. - Common Stock

Atlantic International

Azenta

BioLife Solutions

Bruker

Codexis

Cytek Biosciences

CryoPort

Evotec SE - American Depositary Shares each representing 1/2 of one ordinary share

Evotec

Fortrea Holdings

Lifecore Biomedical

Mesa Laboratories

Maravai LifeSciences Holdings, Inc. - Class A common stock

Maravai LifeSciences

MaxCyte

Niagen Bioscience

OmniAb

Pacific Biosciences of California, Inc. - Common Stock

Pacific Biosciences

Personalis

Quantum-Si Incorporated - Class A Common Stock

Quantum-Si

Quanterix

Rapid Micro Biosystems, Inc. - Class A Common Stock

Rapid Micro Biosystems

Sotera Health

Alpha Teknova

10x Genomics

TD Cowen

Jefferies

バタフライ・ネットワークおよびその他2つの5ドル未満の株
ダウ平均株価指数は金曜日に50ドル以上上昇して取引を終えた。内部者が株を売買した場合、それは同社の見通しに対する彼らの信頼または懸念を示唆する。ペニー株に興味を持つ投資家やトレーダーは、この要素を総合的な投資や取引の意思決定の一因と考えることができよう。
以下に5ドル未満の注目すべきペニー株の最近のインサイダー取引について見てみよう。詳細は<a href="https://www.benzinga.com/sec/insider-trades/">Benzingaのインサイダー取引</a>を参照。
<h3 class="wp-block-heading">Standard BioTools</h3>
<ul>
<li>取引: Standard BioTools Inc(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LAB#NASDAQ">LAB</a>)のCasdin Private Growth Equity Fund、L.P.氏が1.61ドルの平均価格で1,069,562株を<a href="https://www.benzinga.com/sec/insider-trades/">合計1,72百万ドルで購入した</a>。</li>
<li>出来事: 7月31日、Standard BioToolsは決算を発表、予想を下回る結果を報告し、2024年度の売上高見通しも引き下げた。</li>
<li>Standard BioToolsの事業:Standard BioToolsは、バイオメディカル研究者が医薬品をより早く開発するためを支援する技術を開発、製造、販売している。</li>
</ul>
<h3 class="wp-block-heading">Cyanotech</h3>
<ul>
<li>取引: Cyanotech Corporation（OTC：<a class="ticker" href="https://www.benzinga.com/stock/CYAN#OTC">CYAN</a>）のMichael A / Davis氏は、0.73ドルの平均価格で1万株を<a href="https://www.benzinga.com/sec/insider-trades/">合計7,250ドルで購入した</a>。</li>
<li>出来事:8月7日、Cyanotechは2024年6月30日に終了した2025会計年度第1四半期の決算を発表した。</li>
<li>Cyanotechの事業: Cyanotech Corpは、栄養補助食品市場向けのミドロモの自然製品を生産している。</li>
</ul>
<h3 class="wp-block-heading">PHX Minerals</h3>
<ul>
<li>取引: PHX Minerals Inc。(NYSE：<a class="ticker" href="https://www.benzinga.com/stock/PHX#NYSE">PHX</a>) SVP – CFOのRaphael D&#8217;Amico氏は3.30ドルの平均価格で1万株を<a href="https://www.benzinga.com/sec/insider-trades/">合計9,898ドルで購入した</a>。</li>
<li>出来事: 8月12日、PHX Mineralsは第3四半期の決算で予想を上回る結果を報告した。</li>
<li>PHX Mineralsの事業: PHX Minerals Incは、掘削から永久ミネラルおよび天然ガスへの所有権への事業の核心を移行させることを目指している石油・天然ガス鉱物会社。</li>
</ul>
次に読むべきは
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40306547/dow-settles-higher-but-records-weekly-loss-greed-index-remains-in-extreme-fear-zone">ダウは高く推移も週間損失を記録、『極度の恐怖』ゾーンに留まるGreed Index</a></li>
</ul>

Comments

Standard BioTools

ニュース

最新ニュース Standard BioTools (NASDAQ:LAB) 株価情報

月曜日, 8 12, 2024

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル